Global X Genomics & Biotechnology ETF Rating $10.23 -0.06 (-0.58%) (As of 11:34 AM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.67Holdings in GNOM have an aggregate rating of Moderate Buy based on 495 analyst ratings issued in the past year covering 40 companies (97.2% of the portfolio).GNOM Aggregate Price Target$10.20-0.29% DownsideHigh Prediction$10.20Average Prediction$10.20Low Prediction$10.20Holdings in GNOM have an aggregate price target of $10.20 and a range of $10.20 to $10.20 covering 40 companies (97.2% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.62%NTRANatera$165.85-1.4%2.3086 of 5 stars3.00$152.67 -7.9%15Gap Down5.35%VCYTVeracyte$42.244.1701 of 5 stars2.67$41.13 -2.6%9Positive News4.56%ARWRArrowhead Pharmaceuticals$22.16-0.5%4.3771 of 5 stars2.64$42.70 92.7%11Short Interest ↑Analyst Revision4.42%TECHBio-Techne$75.16-0.1%4.3175 of 5 stars2.63$82.00 9.1%8Short Interest ↑Positive News4.38%QGENQiagen$45.23-0.2%4.227 of 5 stars2.60$51.15 13.1%104.29%BNTXBioNTech$116.04-1.2%2.3264 of 5 stars2.82$140.76 21.3%174.24%AAgilent Technologies$136.88+0.3%4.7561 of 5 stars2.43$143.62 4.9%14Short Interest ↓Analyst Revision4.15%CRSPCRISPR Therapeutics$43.91-1.6%1.8963 of 5 stars2.44$77.93 77.5%18Short Interest ↓4.12%ILMNIllumina$140.10-2.1%4.4343 of 5 stars2.70$165.95 18.4%20Short Interest ↑3.92%BEAMBeam Therapeutics$28.87+1.0%3.5093 of 5 stars2.82$47.67 65.1%11Short Interest ↓3.85%SRPTSarepta Therapeutics$123.96-1.4%4.9049 of 5 stars2.91$178.71 44.2%22Insider TradePositive News3.76%BMRNBioMarin Pharmaceutical$66.73-0.7%4.9847 of 5 stars2.74$94.20 41.2%23Positive News3.57%RAREUltragenyx Pharmaceutical$44.07-2.0%4.5688 of 5 stars2.92$87.46 98.5%133.44%ALNYAlnylam Pharmaceuticals$245.27-0.5%4.5509 of 5 stars2.71$298.09 21.5%24Short Interest ↓3.26%LEGNLegend Biotech$34.39-0.8%1.5344 of 5 stars3.00$81.54 137.1%133.21%MRNAModerna$40.39-0.9%4.4049 of 5 stars2.14$79.50 96.8%22Analyst Downgrade3.13%RNAAvidity Biosciences$32.44-0.9%2.5121 of 5 stars3.00$63.60 96.1%103.03%TXG10x Genomics$14.38-2.3%4.5347 of 5 stars2.53$25.14 74.8%172.66%NTLAIntellia Therapeutics$12.91-1.7%4.1788 of 5 stars2.72$54.94 325.5%18Short Interest ↑2.40%MYGNMyriad Genetics$13.824.5684 of 5 stars2.00$24.27 75.6%122.26%CDNACareDx$21.78-1.6%3.7754 of 5 stars2.43$29.60 35.9%7Short Interest ↑2.12%RCKTRocket Pharmaceuticals$12.51+4.9%4.8583 of 5 stars2.92$48.80 290.1%12Analyst ForecastAnalyst RevisionGap Up2.11%GILDGilead Sciences$92.31-0.5%4.5388 of 5 stars2.67$96.43 4.5%27Insider Trade1.99%VRTXVertex Pharmaceuticals$468.07-0.2%4.1985 of 5 stars2.55$505.73 8.0%31Analyst ForecastPositive News1.31%QUREuniQure$16.23-1.4%3.6406 of 5 stars3.00$32.13 97.9%10Analyst ForecastNews Coverage1.30%VIRVir Biotechnology$7.352.2304 of 5 stars2.60$36.40 395.2%51.27%MRVIMaravai LifeSciences$5.62-3.3%4.4938 of 5 stars2.40$10.28 82.9%10Positive News1.15%PSTXPoseida Therapeutics$9.52+0.2%3.7061 of 5 stars2.00$9.50 -0.2%51.10%PACBPacific Biosciences of California$1.971.5354 of 5 stars2.50$2.95 50.0%12Gap Up0.77%RGNXREGENXBIO$8.31-1.9%4.6208 of 5 stars2.92$35.27 324.5%120.74%FLGTFulgent Genetics$19.11-1.7%3.9068 of 5 stars2.00$22.00 15.1%10.73%VERVVerve Therapeutics$5.48-2.3%2.0407 of 5 stars3.00$25.75 369.9%40.72%SGMOSangamo Therapeutics$2.72-3.5%1.8846 of 5 stars2.75$7.00 157.4%4Analyst Upgrade0.55%ALLOAllogene Therapeutics$2.04-1.4%2.9611 of 5 stars2.75$9.73 377.1%12Short Interest ↓0.53%SANASana Biotechnology$1.82-4.7%2.1975 of 5 stars2.75$13.50 641.8%40.33%TSVT2seventy bio$3.12-2.8%2.3305 of 5 stars2.56$9.00 188.5%9Negative News0.31%CRBUCaribou Biosciences$1.84-5.2%2.2279 of 5 stars3.00$10.20 454.3%40.30%EDITEditas Medicine$1.47-3.3%4.4273 of 5 stars2.07$7.00 376.2%14Analyst Forecast0.22%LYELLyell Immunopharma$0.64-0.7%2.4986 of 5 stars1.50$1.00 55.9%20.01%SCLXScilex$0.49-3.9%3.0924 of 5 stars3.00$11.33 2,236.8%3 This page (NASDAQ:GNOM) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts